125 related articles for article (PubMed ID: 25448719)
21. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
[TBL] [Abstract][Full Text] [Related]
22. Biodegradable nanocarriers based on chitosan-modified mesoporous silica nanoparticles for delivery of methotrexate for application in breast cancer treatment.
Shakeran Z; Keyhanfar M; Varshosaz J; Sutherland DS
Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111526. PubMed ID: 33255079
[TBL] [Abstract][Full Text] [Related]
23. Gd-Al co-doped mesoporous silica nanoparticles loaded with Ru(bpy)₃²⁺ as a dual-modality probe for fluorescence and magnetic resonance imaging.
Zhang D; Gao A; Xu Y; Yin XB; He XW; Zhang YK
Analyst; 2014 Sep; 139(18):4613-9. PubMed ID: 25046328
[TBL] [Abstract][Full Text] [Related]
24. Multifunctional mesoporous silica nanoparticles as efficient transporters of doxorubicin and chlorin e6 for chemo-photodynamic combinatorial cancer therapy.
Sun JH; Zhang W; Zhang DY; Shen J; Tan CP; Ji LN; Mao ZW
J Biomater Appl; 2018 Apr; 32(9):1253-1264. PubMed ID: 29448866
[TBL] [Abstract][Full Text] [Related]
25. Mesoporous silica nanoparticles improve magnetic labeling efficiency in human stem cells.
Liu HM; Wu SH; Lu CW; Yao M; Hsiao JK; Hung Y; Lin YS; Mou CY; Yang CS; Huang DM; Chen YC
Small; 2008 May; 4(5):619-26. PubMed ID: 18491363
[TBL] [Abstract][Full Text] [Related]
26. A selective release system based on dual-drug-loaded mesoporous silica for nanoparticle-assisted combination therapy.
Wang W; Wen Y; Xu L; Du H; Zhou Y; Zhang X
Chemistry; 2014 Jun; 20(25):7796-802. PubMed ID: 24863388
[TBL] [Abstract][Full Text] [Related]
27. Theranostic magnetite cluster@silica@albumin double-shell particles as suitable carriers for water-insoluble drugs and enhanced T2 MR imaging contrast agents.
Maboudi SA; Shojaosadati SA; Aliakbari F; Arpanaei A
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():1485-1492. PubMed ID: 30889683
[TBL] [Abstract][Full Text] [Related]
28. Core-shell-type magnetic mesoporous silica nanocomposites for bioimaging and therapeutic agent delivery.
Wang Y; Gu H
Adv Mater; 2015 Jan; 27(3):576-85. PubMed ID: 25238634
[TBL] [Abstract][Full Text] [Related]
29. An anticancer drug delivery system based on surfactant-templated mesoporous silica nanoparticles.
He Q; Shi J; Chen F; Zhu M; Zhang L
Biomaterials; 2010 Apr; 31(12):3335-46. PubMed ID: 20106517
[TBL] [Abstract][Full Text] [Related]
30. Targeted and controlled drug delivery by multifunctional mesoporous silica nanoparticles with internal fluorescent conjugates and external polydopamine and graphene oxide layers.
Tran AV; Shim K; Vo Thi TT; Kook JK; An SSA; Lee SW
Acta Biomater; 2018 Jul; 74():397-413. PubMed ID: 29775731
[TBL] [Abstract][Full Text] [Related]
31. Tailor-made pH-sensitive polyacrylic acid functionalized mesoporous silica nanoparticles for efficient and controlled delivery of anti-cancer drug Etoposide.
Saroj S; Rajput SJ
Drug Dev Ind Pharm; 2018 Jul; 44(7):1198-1211. PubMed ID: 29412022
[TBL] [Abstract][Full Text] [Related]
32. Biocompatible mesoporous silica-coated superparamagnetic manganese ferrite nanoparticles for targeted drug delivery and MR imaging applications.
Sahoo B; Devi KS; Dutta S; Maiti TK; Pramanik P; Dhara D
J Colloid Interface Sci; 2014 Oct; 431():31-41. PubMed ID: 24980623
[TBL] [Abstract][Full Text] [Related]
33. Mesoporous Silica Platforms with Potential Applications in Release and Adsorption of Active Agents.
Chircov C; Spoială A; Păun C; Crăciun L; Ficai D; Ficai A; Andronescu E; Turculeƫ ȘC
Molecules; 2020 Aug; 25(17):. PubMed ID: 32825791
[TBL] [Abstract][Full Text] [Related]
34. Thermo- and pH-responsive, Lipid-coated, Mesoporous Silica Nanoparticle-based Dual Drug Delivery System To Improve the Antitumor Effect of Hydrophobic Drugs.
Feng Y; Li NX; Yin HL; Chen TY; Yang Q; Wu M
Mol Pharm; 2019 Jan; 16(1):422-436. PubMed ID: 30525641
[TBL] [Abstract][Full Text] [Related]
35. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
Zhang W; Liu M; Liu A; Zhai G
Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
[TBL] [Abstract][Full Text] [Related]
36. A magnetic mesoporous silica nanoparticle-based drug delivery system for photosensitive cooperative treatment of cancer with a mesopore-capping agent and mesopore-loaded drug.
Knežević NŽ; Lin VS
Nanoscale; 2013 Feb; 5(4):1544-51. PubMed ID: 23322330
[TBL] [Abstract][Full Text] [Related]
37. Drug delivery/imaging multifunctionality of mesoporous silica-based composite nanostructures.
Chen Y; Chen H; Shi J
Expert Opin Drug Deliv; 2014 Jun; 11(6):917-30. PubMed ID: 24746014
[TBL] [Abstract][Full Text] [Related]
38. Thermo-responsive mesoporous silica/lipid bilayer hybrid nanoparticles for doxorubicin on-demand delivery and reduced premature release.
Zhang Q; Chen X; Shi H; Dong G; Zhou M; Wang T; Xin H
Colloids Surf B Biointerfaces; 2017 Dec; 160():527-534. PubMed ID: 29024917
[TBL] [Abstract][Full Text] [Related]
39. Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis.
She X; Chen L; Yi Z; Li C; He C; Feng C; Wang T; Shigdar S; Duan W; Kong L
Mini Rev Med Chem; 2018; 18(11):976-989. PubMed ID: 27145854
[TBL] [Abstract][Full Text] [Related]
40. Biofunctionalized polymer-lipid supported mesoporous silica nanoparticles for release of chemotherapeutics in multidrug resistant cancer cells.
Zhang X; Li F; Guo S; Chen X; Wang X; Li J; Gan Y
Biomaterials; 2014 Apr; 35(11):3650-65. PubMed ID: 24462359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]